Orexigen Noteholders Say $70M DIP Loan Strips Value
A group of noteholders objected Monday in Delaware bankruptcy court to Orexigen Therapeutics Inc.'s $70.35 million debtor-in-possession loan, saying the financing will strip value from unsecured creditors by requiring the obesity...To view the full article, register now.
Already a subscriber? Click here to view full article